These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 260447)
41. Advances in topical therapy for skin diseases. Willsteed EM Med J Aust; 1996 Sep; 165(5):274-9. PubMed ID: 8816688 [No Abstract] [Full Text] [Related]
42. [The particle size of dexamethasone incorporated in ointments and its relation to the penetration of emulsion ointments into the horny layer of the skin in vivo]. Kleine-Natrop HE Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):425-31. PubMed ID: 1024238 [No Abstract] [Full Text] [Related]
43. Topical antipsoriatics. Smith KC; Lebwohl M Skin Therapy Lett; 2000; 5(2):1-2. PubMed ID: 10751842 [TBL] [Abstract][Full Text] [Related]
44. The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity? Stoughton RB; Wullich K Arch Dermatol; 1989 Nov; 125(11):1509-11. PubMed ID: 2817915 [TBL] [Abstract][Full Text] [Related]
46. [Clinical study of Décoderme cream]. Huriez C; Croquette A Lille Med; 1974 Apr; 19(4 Suppl 11):517-20. PubMed ID: 4612279 [No Abstract] [Full Text] [Related]
47. [Double-blind semilateral study for determination of correct and hazardless dosage of fluprednyliden acetate cream]. Milbradt R Z Allgemeinmed; 1971 Feb; 47(5):246-8. PubMed ID: 4935525 [No Abstract] [Full Text] [Related]
48. Gels and other topical corticosteroids. Med Lett Drugs Ther; 1974 Jun; 16(12):50-2. PubMed ID: 4831241 [No Abstract] [Full Text] [Related]
49. Glucocorticoid action on skin collagen: overview on clinical significance and consequences. Nuutinen P; Autio P; Hurskainen T; Oikarinen A J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):361-2. PubMed ID: 11730056 [No Abstract] [Full Text] [Related]
50. [Experiences with Ehrtolan in general practice]. Dietz O Z Allgemeinmed; 1970 Oct; 46(30):1511-5. PubMed ID: 4394481 [No Abstract] [Full Text] [Related]
51. Irrational use of skin-bleaching products can delay the diagnosis of leprosy. Mahé A; Ly F; Badiane C; Baldé Y; Dangou JM Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):119-21. PubMed ID: 12211896 [No Abstract] [Full Text] [Related]
52. [Reducing the dosage by new technology]. Steinhorst M Hautarzt; 2001 Jan; 52(1):p following 90 (91). PubMed ID: 11220248 [No Abstract] [Full Text] [Related]
53. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents. Rhodes LE; Diffey BL Br J Dermatol; 1997 Jan; 136(1):12-7. PubMed ID: 9039288 [TBL] [Abstract][Full Text] [Related]
54. Topically administered corticosteroids and treatment of inflammatory keratitis. Leibowitz HM; Kupferman A Invest Ophthalmol; 1975 May; 14(5):337-40. PubMed ID: 1126821 [No Abstract] [Full Text] [Related]
55. [Comparison of the efficiency of various externally used corticosteroids]. Horácek J; Semrádová V Z Hautkr; 1974 Jul; 49(13):555-8. PubMed ID: 4423320 [No Abstract] [Full Text] [Related]
56. [External treatment of dermatoses (experiences with Decoderm in dermatologic practice)]. Schuppener HJ Z Haut Geschlechtskr; 1969 Jun; 44(12):441-6. PubMed ID: 5360188 [No Abstract] [Full Text] [Related]
57. [Question of the Month. How do you prescribe the quantity of topical corticoids to be used?]. Crickx B Ann Dermatol Venereol; 1999; 126(6-7):547-52. PubMed ID: 10495873 [No Abstract] [Full Text] [Related]
58. Common forms of dermatitis. An overview of treatments. Bogal CB Adv Nurse Pract; 2010 Jul; 18(7):16. PubMed ID: 20648859 [No Abstract] [Full Text] [Related]